146 related articles for article (PubMed ID: 12725186)
41. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
[TBL] [Abstract][Full Text] [Related]
42. [Expression of human papillomavirus DNA in cholesteatoma of the middle ear].
Bai Y; Yan L; Li S; Bai Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 35(5):352-5. PubMed ID: 12768735
[TBL] [Abstract][Full Text] [Related]
43. Transforming growth factor beta and wound healing in human cholesteatoma.
Huisman MA; de Heer E; Ten Dijke P; Grote JJ
Laryngoscope; 2008 Jan; 118(1):94-8. PubMed ID: 17989584
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
Olszewska E; Chodynicki S; Chyczewski L
Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
[TBL] [Abstract][Full Text] [Related]
45. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
[TBL] [Abstract][Full Text] [Related]
46. Immune cell profile in invasive cholesteatomas: preliminary findings.
Hussein MR; Sayed RH; Abu-Dief EE
Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
[TBL] [Abstract][Full Text] [Related]
47. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
Lang S; Nerlich A; Wiest I; Schreiner M
Laryngorhinootologie; 1994 Jul; 73(7):371-4. PubMed ID: 7916782
[TBL] [Abstract][Full Text] [Related]
48. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
Yu Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
[TBL] [Abstract][Full Text] [Related]
49. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
50. Correlation of vascular morphology with clinical types in cholesteatoma of the middle ear.
Stammberger M; Bujía J; Schulz P
Am J Otol; 1994 May; 15(3):380-2. PubMed ID: 8579144
[TBL] [Abstract][Full Text] [Related]
51. Association between human beta defensin expression and cholesteatoma formation.
Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
53. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
[TBL] [Abstract][Full Text] [Related]
54. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
55. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
[TBL] [Abstract][Full Text] [Related]
56. Expressions of TRPVs in the cholesteatoma epithelium.
Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
[TBL] [Abstract][Full Text] [Related]
58. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
59. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
[TBL] [Abstract][Full Text] [Related]
60. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
